-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Previous studies have confirmed that the plasma of rehabilitation patients is not significant in the treatment of patients hospitalized with neo-coronary pneumonia, and recently researchers examined the effect of plasma treatment in early-rehabilitation patients on improving the inpatients of new coronary pneumonia in old age.
this study, a randomized, double-blind, placebo-controlled study, examined the effects of plasma therapy in patients with mild neocyto pneumonia who received high IgG antibody titration within 72 hours of onset.
endpoint of the study was the worsening of neocyporosis symptoms, defined as breathing frequency of more than 30 times per minute and or oxygen saturation of less than 93%.
This study was terminated early due to the decrease in the number of patients with neo-coronary pneumonia, with 160 patients participating in the group, 80 in each group, 13 in the rehabilitation plasma group, and 25 people in the disease worsening (16% vs. 31%, rr.52), after receiving plasma treatment from recovering patients, the risk of disease deterioration was reduced by 48%, and no serious adverse events were detected.
, for patients with mild neocephaly, receiving high antibody titration recovery plasma within 72 hours of onset can effectively reduce the risk of worsening symptoms in elderly patients.
。